Using experimental, yet realistic, headache calendars, this laboratory study evaluated the ability of individuals to identify the degree of association between triggers and headaches.
使用实验性的，但现实的头痛日历，本实验室研究评估了个体识别触发因素和头痛之间关联程度的能力。
{"title":"Appraisal of Headache Trigger Patterns Using Calendars","authors":"D. P. Turner, L. Leffert, T. Houle","doi":"10.1111/head.13703","DOIUrl":"https://doi.org/10.1111/head.13703","url":null,"abstract":"Using experimental, yet realistic, headache calendars, this laboratory study evaluated the ability of individuals to identify the degree of association between triggers and headaches.","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75335373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
D. Palacios-Ceña, B. Talavera, Víctor Gómez-Mayordomo, D. García‐Azorín, M. Gallego-Gallego, Á. Guerrero, M. Cuadrado
This study aimed to explore the views and experiences of a group of Spanish patients suffering from new daily persistent headache (NDPH).
本研究旨在探讨一组西班牙新发持续性头痛(NDPH)患者的观点和经验。
{"title":"The Day My Life Changed: A Qualitative Study of the Experiences of Patients With New Daily Persistent Headache","authors":"D. Palacios-Ceña, B. Talavera, Víctor Gómez-Mayordomo, D. García‐Azorín, M. Gallego-Gallego, Á. Guerrero, M. Cuadrado","doi":"10.1111/head.13712","DOIUrl":"https://doi.org/10.1111/head.13712","url":null,"abstract":"This study aimed to explore the views and experiences of a group of Spanish patients suffering from new daily persistent headache (NDPH).","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"99 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77564248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
H. Pohl, A. Gantenbein, P. Sandor, J. Schoenen, C. Andrée
The aim of this study was to measure the interictal burden (IIB) associated with cluster headache (CH).
本研究的目的是测量与丛集性头痛(CH)相关的间期负担(IIB)。
{"title":"Interictal Burden of Cluster Headache","authors":"H. Pohl, A. Gantenbein, P. Sandor, J. Schoenen, C. Andrée","doi":"10.1111/head.13711","DOIUrl":"https://doi.org/10.1111/head.13711","url":null,"abstract":"The aim of this study was to measure the interictal burden (IIB) associated with cluster headache (CH).","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"73 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85706114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
T. Schwedt, K. Digre, S. Tepper, Nicole Spare, J. Ailani, Marius Birlea, Mark J. Burish, L. Mechtler, Christopher H Gottschalk, A. Quinn, Linda McGillicuddy, Lisa Bance, Gina M. Dumkrieger, C. Chong, D. Dodick
The American Registry for Migraine Research (ARMR) is a multicenter, prospective, longitudinal patient registry, biorepository, and neuroimaging repository that collects clinical data, electronic health record (EHR) data, blood samples, and brain imaging data from individuals with migraine or other headache types. In this manuscript, we outline ARMR research methods and report baseline data describing an initial cohort of ARMR participants.
{"title":"The American Registry for Migraine Research: Research Methods and Baseline Data for an Initial Patient Cohort","authors":"T. Schwedt, K. Digre, S. Tepper, Nicole Spare, J. Ailani, Marius Birlea, Mark J. Burish, L. Mechtler, Christopher H Gottschalk, A. Quinn, Linda McGillicuddy, Lisa Bance, Gina M. Dumkrieger, C. Chong, D. Dodick","doi":"10.1111/head.13688","DOIUrl":"https://doi.org/10.1111/head.13688","url":null,"abstract":"The American Registry for Migraine Research (ARMR) is a multicenter, prospective, longitudinal patient registry, biorepository, and neuroimaging repository that collects clinical data, electronic health record (EHR) data, blood samples, and brain imaging data from individuals with migraine or other headache types. In this manuscript, we outline ARMR research methods and report baseline data describing an initial cohort of ARMR participants.","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91349482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
F. Khan, A. Mohammed, M. Poongkunran, Anil K Chimakurthy, Michael Pepper
The injection interval for onabotulinumtoxinA (BoNTA) in the management of chronic migraine (CM) is 12 weeks (78‐84 days). The aim of this study was to review patient‐reported wearing off effect (WOE) of the therapeutic benefit of BoNTA near the end of the treatment cycle. We intended to describe the demographics of patients at baseline and compare groups of patients with multiple episodes of WOE.
{"title":"Wearing Off Effect of OnabotulinumtoxinA Near the End of Treatment Cycle for Chronic Migraine: A 4‐Year Clinical Experience","authors":"F. Khan, A. Mohammed, M. Poongkunran, Anil K Chimakurthy, Michael Pepper","doi":"10.1111/head.13713","DOIUrl":"https://doi.org/10.1111/head.13713","url":null,"abstract":"The injection interval for onabotulinumtoxinA (BoNTA) in the management of chronic migraine (CM) is 12 weeks (78‐84 days). The aim of this study was to review patient‐reported wearing off effect (WOE) of the therapeutic benefit of BoNTA near the end of the treatment cycle. We intended to describe the demographics of patients at baseline and compare groups of patients with multiple episodes of WOE.","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79829547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"IV Lidocaine Infusion Leading to the Toxic Levels in Serum Causing Asystole – A Case Report","authors":"L. Digala, S. Lucchese","doi":"10.1111/head.13699","DOIUrl":"https://doi.org/10.1111/head.13699","url":null,"abstract":"","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86472652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This basic review is intended to summarize the current knowledge of methemoglobinemia as an important cause of secondary headache with the hope of generating a growing interest in studying this phenomenon.
{"title":"Headache and Methemoglobinemia","authors":"F. Khan, C. McIntyre, A. Khan, A. Maslov","doi":"10.1111/head.13696","DOIUrl":"https://doi.org/10.1111/head.13696","url":null,"abstract":"This basic review is intended to summarize the current knowledge of methemoglobinemia as an important cause of secondary headache with the hope of generating a growing interest in studying this phenomenon.","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"31 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77198384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
T. Oakes, R. Kovacs, Noah L Rosen, E. Doty, P. Kemmer, S. Aurora, A. Camporeale
Blood pressure (BP), pulse, electrocardiogram (ECG), and clinical cardiovascular (CV) outcomes in patients with episodic or chronic migraine treated for up to 6 months with galcanezumab compared to placebo were evaluated.
{"title":"Evaluation of Cardiovascular Outcomes in Adult Patients With Episodic or Chronic Migraine Treated With Galcanezumab: Data From Three Phase 3, Randomized, Double‐Blind, Placebo‐Controlled EVOLVE‐1, EVOLVE‐2, and REGAIN Studies","authors":"T. Oakes, R. Kovacs, Noah L Rosen, E. Doty, P. Kemmer, S. Aurora, A. Camporeale","doi":"10.1111/head.13684","DOIUrl":"https://doi.org/10.1111/head.13684","url":null,"abstract":"Blood pressure (BP), pulse, electrocardiogram (ECG), and clinical cardiovascular (CV) outcomes in patients with episodic or chronic migraine treated for up to 6 months with galcanezumab compared to placebo were evaluated.","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73624755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neuronal intranuclear inclusion disease (NIID) is considered a heterogeneous disease because of its highly variable clinical manifestations. To date, there are no reports of NIID patients presenting with hemiplegic migraine (HM)‐like headache, or of HM and NIID co‐occurring as comorbidity, and the connection between these 2 seemingly unrelated clinical conditions has yet to be established.
{"title":"Interrelated Pathogenesis? Neuronal Intranuclear Inclusion Disease Combining With Hemiplegic Migraine","authors":"Rong-fei Wang, Xiting Nie, Shi-Tao Xu, Mingjie Zhang, Zhao Dong, Shengyuan Yu","doi":"10.1111/head.13687","DOIUrl":"https://doi.org/10.1111/head.13687","url":null,"abstract":"Neuronal intranuclear inclusion disease (NIID) is considered a heterogeneous disease because of its highly variable clinical manifestations. To date, there are no reports of NIID patients presenting with hemiplegic migraine (HM)‐like headache, or of HM and NIID co‐occurring as comorbidity, and the connection between these 2 seemingly unrelated clinical conditions has yet to be established.","PeriodicalId":12845,"journal":{"name":"Headache: The Journal of Head and Face Pain","volume":"151 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87999835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：